In 1963, Liddle described a family in which multiple siblings developed early-onset severe hypertension and hypokalemia. Genetic studies have revealed mutations in the genes coding the beta or ...

The chlorthalidone group, however, had a significantly higher incidence of hypokalemia (potassium ... in using either agent for the treatment of hypertension and kidney outcomes,” the authors ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

researchers analyzed results from 62 patients referred to a hospital's endocrine unit with suspected primary hyperaldosteronism (usually because of hypertension plus hypokalemia). Final diagnoses ...

Beta blockers are not commonly known to lower potassium levels, and are a well-tolerated drug, said experts on Friday, expre ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently submitted a New Drug Application (NDA) to the U.S. Food and ...

Chlorthalidone is not superior to hydrochlorothiazide in preventing kidney disease progression in patients with hypertension. Chlorthalidone causes slightly more hypokalemia than hydrochlorothiazide.

The findings suggest similar effectiveness for both medications in managing hypertension and protecting kidney health. Hypokalemia can lead to serious health issues, including arrhythmias and muscle ...

hypokalemia, vomiting, hepatic enzyme and bilirubin increased, diarrhea, blood creatinine increased, hypertension, leukopenia and pyrexia. ABSSSI (adult patients): The most common adverse ...

SAB (adult patients): The most common adverse reactions occurring in ≥ 4% of adult patients were anemia, nausea, hypokalemia, vomiting, hepatic enzyme and bilirubin increased, diarrhea, blood ...